Use of Anti-CD3 × Anti-HER2/neu Bispecific Antibody for Redirecting Cytotoxicity of Activated T Cells Toward HER2/neu <sup>+</sup> Tumors
2001 · Journal of Hematotherapy & Stem Cell Research · 95 citations
https://doi.org/10.1089/15258160151134944
L
Lawrence G. Lum
Carter Center(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
478
Papers
7.5K
Citations
44
h-index
139
i10-index
Lawrence G. Lum is an academic researcher from Carter Center. The author has contributed to research in topics: CAR-T cell therapy research & Prostate Cancer Treatment and Research & Immunotherapy and Immune Responses. The author has an h-index of 44, co-authored 407 publications.
ORCID: 0000-0001-7561-6035Papers by this author
worksHuman T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation
2006 · Clinical Cancer Research · 79 citations
https://doi.org/10.1158/1078-0432.ccr-05-2005
Anti‐CD3 × anti‐GD2 bispecific antibody redirects T‐cell cytolytic activity to neuroblastoma targets
2012 · Pediatric Blood & Cancer · 78 citations
https://doi.org/10.1002/pbc.24237
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
2014 · Journal of Translational Medicine · 49 citations
https://doi.org/10.1186/s12967-014-0347-2
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma
2013 · Biology of Blood and Marrow Transplantation · 39 citations
https://doi.org/10.1016/j.bbmt.2013.03.010
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
2013 · BMC Cancer · 37 citations
https://doi.org/10.1186/1471-2407-13-83
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat